According to the study, all the retrieved MPXV sequences from India covering 90 to 99 per cent of the genome belong to the A.2 lineage of clade IIb.
The ICMR study is a multi-centric study to determine the incidence, morbidity, mortality and economic burden of snakebites in India covering all five geographical zones of the country.
The findings of the study, conducted in February this year after isolating the Omicron variant, have been published in the Journal of Infection on April 5.
"As for the directions given or not given by the Prime Minister, I would like to inform everyone that it is because of the PM's timely and correct directions that India has been able to do the best Covid management and vaccination," said Mandaviya to the house.
As per the recommendation of the National Technical Advisory Group on Immunization (NTAGI), precaution dose is administered to healthcare workers, frontline workers, and people aged 60 years and above since January 10,2022, she said.
Infection by one variant does not provide protection from the other variants, Indian Council of Medical Research Director General Dr Balram Bhargava said on Thursday.
However, the study has a limitation of lesser participants in the unvaccinated group and the shorter window period post infection. "This could be the important reason for the low immune response specifically in the unvaccinated individuals against Omicron," it said.
The advisory also stated that asymptomatic individuals in community settings and contacts of confirmed cases of Covid-19 need not undergo testing unless the patient is identified as high risk based on age and comorbidities.
About three studies from India - two by the ICMR and one from Bombay conducted on 284, 755 and 244 patients, respectively, Bhargava said that immunity persists for up to 8 months, 7 months, and 6 months respectively.
The ICMR-Regional Medical Research Centre, NE, Dibrugarh has developed a novel technology -- real-time RT-PCR assay for detection of Omicron (B.1.1.529) variant of SARS-CoV2 and a kit for the same.
The kit is now being produced on a bulk basis by the West Bengal-based GCC Biotech on a public-private partnership (PPP) model.
The World Health Organization (WHO) has classified the new Covid variant detected in South Africa this week as the 'Variant of Concern' -- VOC, following the Technical Advisory Group meetings.
The total number of COVID-19 vaccine doses administered in the country has exceeded 116.87 crore, according to provisional reports till 7 am.
A latest study by the Indian Council of Medical Research (ICMR) revealed that Cuttack reports the maximum instances of brain stroke cases among cities in India.
Covaxin Gets WHO Nod; Union Health Minister’s Reaction
The Drugs and Comptroller General of India (DCGI) has given a go-ahead to Bharat Biotech's Covaxin for vaccination of children in the 2-18 years age group.
School teachers, staff and those involved in the transportation of children should be vaccinated on an emergent basis and continue to use a mask even after receiving the jabs, the experts underlined.
There is no difference in antibodies produced by Covaxin and Covishield vaccines against the Covid-19 virus. This information was shared by Odisha Health Services Director Bijay Mohapatra on Monday (Sept 27).
Seventy-three percent people in Odisha have developed antibodies against Covid-19. This information was given by director of RMRC (Regional Medical Research Centre), Sanghamitra Pati on Sunday (Sept 26).
Childhood cancers rank ninth as a leading cause of childhood diseases at the global level, accounting for 11.5 million of the Disability Adjusted Life Years (DALYs).